|
1
|
Grysiewicz RA, Thomas K and Pandey DK:
Epidemiology of ischemic and hemorrhagic stroke: incidence,
prevalence, mortality, and risk factors. Neurol Clin. 26:871–895.
vii2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Asch CJ, Luitse MJ, Rinkel GJ, et al:
Incidence, case fatality, and functional outcome of intracerebral
haemorrhage over time, according to age, sex, and ethnic origin: a
systematic review and meta-analysis. Lancet Neurol. 9:167–176.
2010.PubMed/NCBI
|
|
3
|
Wolf PA, Belanger AJ and D’Agostino RB:
Management of risk factors. Neurol Clin. 10:177–191. 1992.
|
|
4
|
Lanktree MB, Dichgans M and Hegele RA:
Advances in genomic analysis of stroke: what have we learned and
where are we headed? Stroke. 41:825–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ikram MA, Seshadri S, Bis JC, et al:
Genomewide association studies of stroke. N Engl J Med.
360:1718–1728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Somarajan BI, Kalita J, Mittal B and Misra
UK: Evaluation of MTHFR C677T polymorphism in ischemic and
hemorrhagic stroke patients. A case-control study in a Northern
Indian population. J Neurol Sci. 304:67–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tao HM, Chen GZ, Lu XD, Chen GP and Shao
B: TGF-β1 869T/C polymorphism and ischemic stroke: sex difference
in Chinese. Can J Neurol Sci. 37:803–807. 2010.
|
|
8
|
Kim NS, Ko MM, Cha MH, Oh SM and Bang OS:
Age and sex dependent genetic effects of neuropeptide Y promoter
polymorphism on susceptibility to ischemic stroke in Koreans. Clin
Chim Acta. 411:1243–1247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han IB, Kim OJ, Ahn JY, et al: Association
of methylenetetrahydrofolate reductase (MTHFR 677C>T and
1298A>C) polymorphisms and haplotypes with silent brain
infarction and homocysteine levels in a Korean population. Yonsei
Med J. 51:253–260. 2010.
|
|
10
|
Kim OJ, Hong SP, Ahn JY, et al: Influence
of combined methionine synthase (MTR 2756A > G) and
methylenetetrahydrofolate reductase (MTHFR 677C > T)
polymorphisms to plasma homocysteine levels in Korean patients with
ischemic stroke. Yonsei Med J. 48:201–209. 2007.
|
|
11
|
Kim YS, Yoo JH and Lee BC: Susceptibility
for ischemic stroke in Korean population is associated with
polymorphisms of the Fc gamma receptor IIA. Blood Coagul
Fibrinolysis. 20:353–357. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee BC, Ahn SY, Doo HK, et al:
Susceptibility for ischemic stroke in Korean population is
associated with polymorphisms of the interleukin-1 receptor
antagonist and tumor necrosis factor-alpha genes, but not the
interleukin-1beta gene. Neurosci Lett. 357:33–36. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee BC, Lee H, Park HK, Yang JS and Chung
JH: Susceptibility for ischemic stroke in four constitution
medicine is associated with polymorphisms of FCGR2A and IL1RN
genes. Neurol Res. 32(Suppl 1): 43–47. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park SA, Park BL, Park JH, et al:
Association of polymorphisms in thromboxane A2 receptor and
thromboxane A synthase 1 with cerebral infarction in a Korean
population. BMB Rep. 42:200–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim MK, Kim JT, Choi SM, et al:
Phosphodiesterase 4D gene and risk of noncardiogenic ischemic
stroke in a Korean population. J Korean Med Sci. 24:307–310. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Um JY and Kim HM: Polymorphisms of RANTES
and IL-4 genes in cerebral infarction. J Mol Neurosci. 37:1–5.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SH, Kim MK, Park MS, et al:
beta-Fibrinogen gene-455 G/A polymorphism in Korean ischemic stroke
patients. J Clin Neurol. 4:17–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang SY and Lee WI: Apolipoprotein E
polymorphism in ischemic stroke patients with different
pathogenetic origins. Korean J Lab Med. 26:210–216. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shin BS, Oh SY, Kim YS and Kim KW: The
paraoxonase gene polymorphism in stroke patients and lipid profile.
Acta Neurol Scand. 117:237–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee BC, Doo HK, Ahn SY, et al: Peroxisome
proliferator-activated receptor-gamma Pro12Ala polymorphism is
associated with the susceptibility to ischemic stroke in Taeeumin
classified by Sasang medicine. Neurol Res. 29(Suppl 1): S32–S37.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim Y, Kim JH, Nam YJ, et al: Klotho is a
genetic risk factor for ischemic stroke caused by cardioembolism in
Korean females. Neurosci Lett. 407:189–194. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seo JC, Han SW, Yin CS, et al: Evaluation
of a Apo-1/Fas promoter polymorphism in Korean stroke patients. Exp
Mol Med. 34:294–298. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marciante KD, Bis JC, Rieder MJ, et al:
Renin-angiotensin system haplotypes and the risk of myocardial
infarction and stroke in pharmacologically treated hypertensive
patients. Am J Epidemiol. 166:19–27. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brenner D, Labreuche J, Poirier O, Cambien
F and Amarenco P; GENIC Investigators:
Renin-angiotensin-aldosterone system in brain infarction and
vascular death. Ann Neurol. 58:131–138. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong SH, Park HM, Ahn JY, et al: ACE I/D
polymorphism in Korean patients with ischemic stroke and silent
brain infarction. Acta Neurol Scand. 117:244–249. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saidi S, Mallat SG, Almawi WY and Mahjoub
T: Association between renin-angiotensin-aldosterone system
genotypes and haplotypes and risk of ischemic stroke of
atherosclerotic etiology. Acta Neurol Scand. 119:356–363. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Um JY, Moon KS, Lee KM, et al:
Polymorphism of angiotensin-converting enzyme, angiotensinogen, and
apolipoprotein E genes in Korean patients with cerebral infarction.
J Mol Neurosci. 21:23–28. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Morimoto S, Cassell MD, Beltz TG, et al:
Elevated blood pressure in transgenic mice with brain-specific
expression of human angiotensinogen driven by the glial fibrillary
acidic protein promoter. Circ Res. 89:365–372. 2001. View Article : Google Scholar
|
|
29
|
Sherrod M, Davis DR, Zhou X, Cassell MD
and Sigmund CD: Glial-specific ablation of angiotensinogen lowers
arterial pressure in renin and angiotensinogen transgenic mice. Am
J Physiol Regul Integr Comp Physiol. 289:R1763–R1769. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hajjar I, Sorond F, Hsu YH, et al: Renin
angiotensin system gene polymorphisms and cerebral blood flow
regulation: the MOBILIZE Boston study. Stroke. 41:635–640. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Buroker NE, Ning XH, Zhou ZN, et al:
Genetic associations with mountain sickness in Han and Tibetan
residents at the Qinghai-Tibetan Plateau. Clin Chim Acta.
411:1466–1473. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gomez-Gallego F, Santiago C,
Gonzalez-Freire M, et al: The C allele of the AGT Met235Thr
polymorphism is associated with power sports performance. Appl
Physiol Nutr Metab. 34:1108–1111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yugar-Toledo JC, Martin JF, Krieger JE, et
al: Gene variation in resistant hypertension: multilocus analysis
of the angiotensin 1-converting enzyme, angiotensinogen, and
endothelial nitric oxide synthase genes. DNA Cell Biol. 30:555–564.
2011. View Article : Google Scholar
|
|
34
|
Conen D, Glynn RJ, Buring JE, Ridker PM
and Zee RY: Association of renin-angiotensin and endothelial nitric
oxide synthase gene polymorphisms with blood pressure progression
and incident hypertension: prospective cohort study. J Hypertens.
26:1780–1786. 2008. View Article : Google Scholar
|
|
35
|
Underwood PC, Sun B, Williams JS, et al:
The association of the angiotensinogen gene with insulin
sensitivity in humans: a tagging single nucleotide polymorphism and
haplotype approach. Metabolism. 60:1150–1157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Conen D, Glynn RJ, Buring JE, Ridker PM
and Zee RY: Renin-angiotensin and endothelial nitric oxide synthase
gene polymorphisms are not associated with the risk of incident
type 2 diabetes mellitus: a prospective cohort study. J Intern Med.
263:376–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ahluwalia TS, Ahuja M, Rai TS, et al: ACE
variants interact with the RAS pathway to confer risk and
protection against type 2 diabetic nephropathy. DNA Cell Biol.
28:141–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang QS, Li YG, Chen XD, et al:
Angiotensinogen polymorphisms and acquired atrial fibrillation in
Chinese. J Electrocardiol. 43:373–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Freitas AI, Mendonca I, Brion M, et al:
RAS gene polymorphisms, classical risk factors and the advent of
coronary artery disease in the Portuguese population. BMC
Cardiovasc Disord. 8:152008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsai CT, Hwang JJ, Lai LP, et al:
Interaction of gender, hypertension, and the angiotensinogen gene
haplotypes on the risk of coronary artery disease in a large
angiographic cohort. Atherosclerosis. 203:249–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zakrzewski-Jakubiak M, de Denus S, Dube
MP, et al: Ten reninangiotensin system-related gene polymorphisms
in maximally treated Canadian Caucasian patients with heart
failure. Br J Clin Pharmacol. 65:742–751. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Renner W, Nauck M, Winkelmann BR, et al:
Association of angiotensinogen haplotypes with angiotensinogen
levels but not with blood pressure or coronary artery disease: the
Ludwigshafen Risk and Cardiovascular Health Study. J Mol Med
(Berl). 83:235–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sethi AA, Tybjaerg-Hansen A, Gronholdt ML,
et al: Angiotensinogen mutations and risk for ischemic heart
disease, myocardial infarction, and ischemic cerebrovascular
disease. Six case-control studies from the Copenhagen City Heart
Study. Ann Intern Med. 134:941–954. 2001. View Article : Google Scholar
|
